ATE413166T1 - Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff - Google Patents

Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff

Info

Publication number
ATE413166T1
ATE413166T1 AT05077630T AT05077630T ATE413166T1 AT E413166 T1 ATE413166 T1 AT E413166T1 AT 05077630 T AT05077630 T AT 05077630T AT 05077630 T AT05077630 T AT 05077630T AT E413166 T1 ATE413166 T1 AT E413166T1
Authority
AT
Austria
Prior art keywords
melting point
drug
plaster containing
transdermal plaster
excipient
Prior art date
Application number
AT05077630T
Other languages
English (en)
Inventor
Toshiro Yamaguchi
Mitsuru Kuribayashi
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE413166T1 publication Critical patent/ATE413166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05077630T 2004-11-22 2005-11-21 Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff ATE413166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004336871 2004-11-22

Publications (1)

Publication Number Publication Date
ATE413166T1 true ATE413166T1 (de) 2008-11-15

Family

ID=35809740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05077630T ATE413166T1 (de) 2004-11-22 2005-11-21 Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff

Country Status (5)

Country Link
US (1) US7744918B2 (de)
EP (1) EP1661560B1 (de)
AT (1) ATE413166T1 (de)
DE (1) DE602005010812D1 (de)
ES (1) ES2317138T3 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
ATE438418T1 (de) 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical Hydrogel-zusammensetzungen
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
AU2002316053A1 (en) 2001-05-01 2002-11-11 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
WO2005117886A1 (ja) * 2004-06-01 2005-12-15 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
CA2653827C (en) * 2006-06-09 2014-04-08 Dainippon Sumitomo Pharma Co., Ltd. Novel blonanserin tape preparation
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법
KR101408488B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
EP1985290A1 (de) * 2007-04-26 2008-10-29 Sansho Cosme Inc. Auf die Haut aufzutragendes Medikament, Verfahren zu seiner Auftragung auf der Haut und Verfahren zu seiner Herstellung
CN103239721B (zh) * 2007-11-22 2016-03-16 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
EP2258396B1 (de) * 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermal absorbierbares präparat
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
EP2279739B2 (de) * 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezilhaltiges pflasterpräparat und dessen verpackung
WO2010016219A1 (ja) * 2008-08-05 2010-02-11 株式会社メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
WO2010083035A2 (en) * 2009-01-14 2010-07-22 Corium International, Inc. Transdermal administration of tamsulosin
US8815261B2 (en) 2009-06-19 2014-08-26 Medrx Co., Ltd. Composition for external application comprising aripiprazole and organic acid as active ingredients
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
CN103501770B (zh) * 2011-04-18 2015-04-29 久光制药株式会社 贴附剂的制造方法及贴附剂
HUE066287T2 (hu) 2011-04-25 2024-07-28 Geneora Pharma Shijiazhuang Co Ltd Nyújtott leadású mikroszféra risperidon készítmény
CA2885941A1 (en) 2012-09-28 2014-04-03 Delpor, Inc. Device and method for sustained release of antipsychotic medications
GB201317718D0 (en) 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
EP3062819B1 (de) 2013-11-03 2021-12-22 The Regents of The University of California Ionische flüssigkeiten zur transdermalen arzneimittelverabreichung
US10835499B2 (en) 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
CN109922796B (zh) 2016-06-23 2023-04-07 考里安有限责任公司 具有亲水和疏水域的粘合剂基质和治疗剂
EP3490544A1 (de) 2016-07-27 2019-06-05 Corium International, Inc. Transdermale abgabesysteme für memantin
JP7071330B2 (ja) 2016-07-27 2022-05-18 コリウム， インコーポレイテッド 炭酸水素ナトリウムのｉｎ ｓｉｔｕ変換で促進されたアミン薬物の経皮送達
US10912834B2 (en) 2016-08-29 2021-02-09 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
US10828265B2 (en) * 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
CN110087641B (zh) 2016-12-20 2024-03-12 罗曼治疗系统股份公司 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统
KR102279552B1 (ko) * 2016-12-28 2021-07-19 히사미쓰 세이야꾸 가부시키가이샤 부토르파놀 함유 첩부제
TWI783984B (zh) 2017-04-05 2022-11-21 日商帝國製藥股份有限公司 含有利培酮之貼附劑
JP6704514B2 (ja) * 2017-04-25 2020-06-03 久光製薬株式会社 貼付剤
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
KR102024996B1 (ko) * 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
CN118806732A (zh) 2018-06-20 2024-10-22 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
BR112020026099A2 (pt) 2018-06-20 2021-03-23 Lts Lohmann Therapie-Systeme Ag sistema terapêutico transdérmico que contém asenapina
US11559525B2 (en) 2019-04-26 2023-01-24 Sumitomo Pharma Co., Ltd. Therapeutic drug for dyskinesia
US10758535B1 (en) 2019-04-26 2020-09-01 Sumitomo Dainippon Pharma Co., Ltd. Therapeutic drug for dyskinesia
CA3168199A1 (en) * 2020-02-19 2021-08-26 Eri ICHIBAYASHI Transdermal absorption preparation
JPWO2022045336A1 (de) 2020-08-31 2022-03-03
CN121731255B (zh) * 2026-02-27 2026-05-22 国药瑞福莱药业有限公司 一种缓控释透皮贴剂及其制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DE69009540T2 (de) * 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
JP2944010B2 (ja) 1992-06-25 1999-08-30 オークマ株式会社 ヒートシンク
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
TW592729B (en) 1995-04-06 2004-06-21 Janssen Pharmaceutica Nv Rate-controlled transdermal administration of risperidone
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
FR2758263B1 (fr) 1997-01-16 1999-12-17 Oreal Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
EP1165090A2 (de) 1999-03-18 2002-01-02 Children's Hospital Research Foundation Verfahren zur behandlung von bulimia nervosa und damit in verbindung stehende esstörungen durch die verabreichung von atypischen antipsychotika
EP1170004B1 (de) 1999-04-13 2010-10-27 Hisamitsu Pharmaceutical Co., Inc. Zubereitungen zur perkutanen absorption
CA2378385C (en) 1999-07-27 2009-01-27 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use including an acid addition salt of a basic drug
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
JP2005082512A (ja) 2003-09-05 2005-03-31 Medorekkusu:Kk イオン性の薬物の経皮吸収性を高めた外用剤
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system

Also Published As

Publication number Publication date
EP1661560B1 (de) 2008-11-05
ES2317138T3 (es) 2009-04-16
EP1661560A1 (de) 2006-05-31
US7744918B2 (en) 2010-06-29
US20060110434A1 (en) 2006-05-25
DE602005010812D1 (de) 2008-12-18

Similar Documents

Publication Publication Date Title
DE602005010812D1 (de) Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
EP1928537A4 (de) Vorrichtungen für die transkutane abgabe von vakzinen und transdermale abgabe von arzneimitteln und ihre verwendungen
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
ATE468332T1 (de) Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
SE0401342D0 (sv) Therapeutic compounds
HUS1500018I1 (hu) A Bruton-féle tirozin-kináz inhibitorai
UY28923A1 (es) Compuestos terapéuticos: piridina como estructura base
EA200901155A1 (ru) Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
CY1112478T1 (el) Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
DE602005011653D1 (de) Medizinprodukt mit gewebeabhängiger arzneimittelelution
MX2009006007A (es) Profarmacos y metodos para hacer y usar los mismos.
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
SE0401971D0 (sv) Piperidne derivatives
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
NO20064792L (no) Anvendelse av rotigotin til behandling og forbinding av Parkinsons pluss syndrom.
SG157402A1 (en) Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
ATE400257T1 (de) Stabile pharmazeutische zusammensetzung mit linezolid form iv
PL1765310T3 (pl) Mieszanina do podawania przezskórnego nisko- i wysokocząsteczkowych związków
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
HRP20080146T3 (en) Preoperative treatment of post operative pain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties